Topic

Humana

A collection of 599 issues

Renewing Signifor LAR (Pasireotide) Coverage with Humana in California: Timeline, Documentation, and Appeals Guide

Answer Box: Renewing Your Signifor LAR Coverage Renewal triggers: Submit 30-45 days before current authorization expires. Key evidence: Updated UFC/IGF-1 labs showing response, recent clinic notes, and prescriber attestation of continued necessity. California advantage: If Humana denies renewal, file an Independent Medical Review (IMR) through DMHC—72% overall success
5 min read

How to Get Ilaris (Canakinumab) Covered by Humana in California: Prior Authorization Guide and Appeal Process

Quick Answer: Getting Ilaris (Canakinumab) Covered by Humana in California Humana requires prior authorization for Ilaris (canakinumab) with step therapy documentation and medical necessity justification. If denied, California residents have strong appeal rights through the DMHC Independent Medical Review (IMR) process with a 73% success rate. Start today: Have your
5 min read

How to Get Fintepla (fenfluramine) Covered by Humana in Virginia: Prior Authorization Forms, Appeals, and Step-by-Step Guide

Quick Answer: Getting Fintepla Covered by Humana in Virginia To get Fintepla (fenfluramine) covered by Humana in Virginia, you need prior authorization with specific documentation: confirmed Dravet syndrome or Lennox-Gastaut syndrome diagnosis, evidence of at least two failed antiseizure medications, baseline echocardiogram results, and enrollment in the FDA REMS program.
6 min read

How to Get Voxzogo (Vosoritide) Covered by Humana in Pennsylvania: 2025 Prior Authorization Guide

Answer Box: Getting Voxzogo (Vosoritide) Covered by Humana in Pennsylvania Eligibility: Humana requires prior authorization for Voxzogo (vosoritide) with confirmed achondroplasia, open growth plates, and pediatric specialist care. Fastest path: Submit complete PA packet including FGFR3 genetic test, growth plate imaging, and pediatric endocrinologist letter through Humana's provider
5 min read